MORGAN STANLEY PLC/CALL/AMGEN/460/0.1/20.06.25 | Market Closed - Börse Stuttgart 02:39:40 2024-05-20 pm EDT | ||
| 0.53 EUR | +3.92% |
|
| Current month | +103.85% | ||
| 1 month | +76.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-20 | 0.53 | +3.92% |
| 24-05-17 | 0.51 | -5.56% |
| 24-05-16 | 0.54 | -5.26% |
| 24-05-15 | 0.57 | +14.00% |
| 24-05-14 | 0.5 | +4.17% |
Delayed Quote Börse Stuttgart
Last update May 20, 2024 at 02:39 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME6QP9 |
| ISIN | DE000ME6QP90 |
| Date issued | 2024-01-10 |
| Strike | 460 $ |
| Maturity | 2025-06-20 (396 Days) |
| Parity | 10 : 1 |
| Emission price | 0.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.69 € |
|---|---|
| Lowest since issue | 0.21 € |
| Spread | 0.03 € |
| Spread % | 5.36% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
314.5
USD
Average target price
316.1
USD
Spread / Average Target
+0.48%
- Stock Market
- Warrants
- Warrant
